product name Mitiglinide Calcium
Description: Mitiglinide Calcium is a Potassiun Channel blocker that is used as a blood glucose-lowering drug, it stimulates insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells. Mitiglinide may be potential useful for the treatment of type 2 diabetes.
References: Endocr J. 2015;62(12):1049-57; BMJ Open Diabetes Res Care. 2015 Aug 28;3(1):e000122.
668.88
Formula
(C19H24NO3)2.Ca
CAS No.
145525-41-3
Storage
-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)
DMSO: <1 mg/mL
Water: <1 mg/mL
Ethanol: 2 mg/mL (2.99 mM)
Solubility (In vivo)
Synonyms
KAD-1229
other peoduct :
| In Vitro |
In vitro activity: Kinase Assay: Cell Assay: |
|---|---|
| In Vivo | |
| Animal model | |
| Formulation & Dosage | |
| References |
